$205.570
-2.282 (-1.11%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RVMD 相似图表分析预测
Alphio's RVMD stock price prediction model matches the current Revolution Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $211.61 (+0.83%). The 1-week path is $215.68 (+2.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Revolution Medicines Inc 股票吗？
Revolution Medicines Inc is a good buy right now due to the recent FDA approval of its drug Rasonque, which is projected to generate $28 million in sales this quarter and has a long-term sales potential of $11.5 billion. Additionally, the stock has seen a remarkable year-to-date change of +163.07% and is currently priced at $207.88, with analysts raising price targets significantly, indicating strong future upside.
RVMD 股价于 Monday 收于 $205.57，此前下跌 -1.11%
Revolution Medicines Inc (RVMD) last closed at $209.87, gaining +2.09%. These facts feed the 1-day and 1-week RVMD price prediction above.
预测驱动因素
Revolution Medicines Inc（RVMD）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 RVMD 最接近的股票，按相似度排序。
RVMD 季节性分析
Historically the probability of a positive September return for RVMD is 71.43%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。